Condition (MeSH)
Vulvar Vestibulitis
ClinicalTrials.gov lists 19 trials for Vulvar Vestibulitis or a narrower condition beneath it. Western Galilee Hospital-Nahariya has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
19 of the 19 trials are tagged with Vulvar Vestibulitis itself; the rest are tagged with a narrower condition beneath it.
When did Vulvar Vestibulitis trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2022 | 1 |
| 2018 | 3 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 1 |
| 2011 | 2 |
| 2009 | 2 |
| 2006 | 2 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Vulvar Vestibulitis trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 11 |
| Observational | 2 |
How many Vulvar Vestibulitis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 11 |
| Terminated | 4 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Vulvar Vestibulitis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Western Galilee Hospital-Nahariya | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Which drugs are being tested for Vulvar Vestibulitis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Pregabalin | 1 |
| Botulinum Toxin | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Acupuncture | 2 |
| Standard Care | 1 |
| Capsaicin 8% | 1 |
| 5% topical lidocaine ointment | 1 |
| L:Lidocaine | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Vulvar Vestibulitis? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. | Obstetrics and gynecology | 2014 | Yes |
| The bacterial microbiome in paired vaginal and vestibular samples from women with vulvar vestibulitis syndrome. | Pathogens and disease | 2014 | Yes |
| Pain, psychosocial, sexual, and psychophysical characteristics of women with primary vs. secondary provoked vestibulodynia. | The journal of sexual medicine | 2009 | Yes |
| Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. | Obstetrics and gynecology | 2009 | Yes |
| The treatment of provoked vestibulodynia: a critical review. | The Clinical journal of pain | 2008 | Yes |
Showing 5 of 8 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.